We are live on ! Find out more
NAM

Nexpoint Asset Management Portfolio holdings

AUM $1.49B
1-Year Est. Return 61.08%
This Fund
S&P 500
This Quarter Est. Return
+21.63%
1 Year Est. Return
+61.08%
3 Year Est. Return
+208.69%
5 Year Est. Return
+685.71%
10 Year Est. Return
AUM
$304M
AUM Growth
-$138M
Cap. Flow
-$182M
Cap. Flow %
-60.02%
Top 10 Hldgs %
43.63%
Holding
203
New
45
Increased
4
Reduced
23
Closed
60

Sector Composition

Rank Sector Weight
1 Healthcare 16.91%
2 Energy 14.97%
3 Technology 14.48%
4 Real Estate 11.52%
5 Utilities 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
101
Linde
LIN
$226B
$527K 0.17%
2,000
TNDM icon
102
Tandem Diabetes Care
TNDM
$1.29B
$526K 0.17%
5,500
CFIVU
103
DELISTED
CF Acquisition Corp. IV Unit
CFIVU
$515K 0.17%
+50,000
New +$516K
GRSV
104
DELISTED
Gores Holdings V, Inc.
GRSV
$514K 0.17%
+49,469
New +$495K
PDCO
105
DELISTED
Patterson Companies, Inc.
PDCO
$510K 0.17%
17,200
BDX icon
106
Becton Dickinson
BDX
$48.8B
$500K 0.16%
2,050
INTC icon
107
Intel
INTC
$503B
$498K 0.16%
10,000
-10,000
-50% -$488K
CHFW.U
108
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$492K 0.16%
+38,628
New +$395K
LOMA
109
Loma Negra
LOMA
$1.26B
$474K 0.16%
77,050
ESTA icon
110
Establishment Labs
ESTA
$2.33B
$452K 0.15%
12,000
SGRY icon
111
Surgery Partners
SGRY
$1.95B
$452K 0.15%
15,580
PAGP icon
112
Plains GP Holdings
PAGP
$5.02B
$450K 0.15%
53,200
AMT icon
113
American Tower
AMT
$79.8B
$449K 0.15%
2,000
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$11.9B
$438K 0.14%
5,000
STNE icon
115
StoneCo
STNE
$2.69B
$420K 0.14%
5,000
PTICU
116
DELISTED
PropTech Investment Corporation II Unit
PTICU
$411K 0.14%
+38,206
New +$396K
SUPV
117
Grupo Supervielle
SUPV
$763M
$400K 0.13%
188,858
TDOC icon
118
Teladoc Health
TDOC
$1.21B
$400K 0.13%
2,000
-6,000
-75% -$1.22M
INSM icon
119
Insmed
INSM
$28.7B
$399K 0.13%
12,000
STND
120
DELISTED
Standard AVB Financial Corp. Common Stock
STND
$380K 0.13%
+11,645
New +$382K
ARA
121
DELISTED
American Renal Associates Holdings, Inc
ARA
$328K 0.11%
+28,630
New +$326K
MBIO icon
122
Mustang Bio
MBIO
$4.36M
$322K 0.11%
113
KKR icon
123
KKR & Co
KKR
$92.8B
$284K 0.09%
7,013
BKD icon
124
Brookdale Senior Living
BKD
$3.43B
$273K 0.09%
61,625
VIIAU
125
DELISTED
7GC & Co Holdings Unit
VIIAU
$264K 0.09%
+25,000
New +$261K

Similar funds

Nexpoint Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Nexpoint Asset Management held 203 positions worth $304M, down 31% from $442M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Nexpoint Asset Management withdrew a net $182M in Q4 2020, closing 60 positions and reducing 23 holdings. Its most notable exit was Castle Biosciences, an estimated $36.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 20% a quarter earlier, followed by Energy and Technology.

Against the trend, Nexpoint Asset Management opened a new position in Tiffany & Co. worth $7.27M.

  • Nexpoint Asset Management's largest Q4 2020 buy was Tiffany & Co.: 55,283 shares worth $7.27M.
  • Nexpoint Asset Management added most to Advanced Micro Devices in Q4 2020, an estimated $604K increase.
  • Nexpoint Asset Management's biggest Q4 2020 reduction was Vistra, cutting an estimated $43M.
  • Nexpoint Asset Management fully exited Castle Biosciences in Q4 2020, selling an estimated $36.4M.
  • Nexpoint Asset Management's ten largest holdings make up 44% of its $304M portfolio in Q4 2020.
  • Nexpoint Asset Management opened 45 new positions and closed 60 in Q4 2020.
  • Nexpoint Asset Management's portfolio value fell 31% quarter-over-quarter to $304M.

Based on Nexpoint Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.